ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹881 Cr | ₹92 Cr | ₹285 Cr | ₹269 Cr | ₹292 Cr |
What is the latest Contingent Liabilities ratio of ALKEM LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹881 Cr |
Mar2024 | ₹92 Cr |
Mar2023 | ₹285 Cr |
Mar2022 | ₹269 Cr |
Mar2021 | ₹292 Cr |
How is Contingent Liabilities of ALKEM LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹881 Cr | 860.69 | |
Mar2024 | ₹92 Cr | -67.77 | |
Mar2023 | ₹285 Cr | 5.93 | |
Mar2022 | ₹269 Cr | -7.89 | |
Mar2021 | ₹292 Cr | - |
Compare Contingent Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹60,374.7 Cr | 1.5% | 2.9% | -3.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,595.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,635.0 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
CIPLA | ₹126,894.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,685.0 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,373.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 1.5% |
2.9% |
-3.1% |
SENSEX | -1.6% |
-3.4% |
0.9% |
You may also like the below Video Courses